- The Phillies reportedly showed interest in left-hander Dallas Keuchel during his long stay in free agency, but the 31-year-old suggested Wednesday that wasn’t the case. “If you don’t come calling, what is there for me to be mad about? I think a lot of those guys over there in that front office are second-guessing themselves. I would too,” Keuchel said to Gabriel Burns of the Atlanta Journal-Constitution and other reporters. He made those comments after stymieing the Phillies with six innings of one-run ball in a 3-1 victory for the Braves. Despite the defeat, the Phillies (75-70) are still just two games back of a wild-card spot, though they might be in better position had they signed Keuchel. The former AL Cy Young winner has posted a terrific 3.35 ERA over 96 2/3 innings since joining the Braves on a one-year, $13MM contract in June. While Keuchel’s peripherals aren’t as impressive, he’d still rank among the absolute best starters on a Philly team whose rotation has fallen flat in 2019.
Phillies Rumors
Early Trade Deadline Re-Assessment: NL East
It has only been a little over five weeks, so it’s too soon to judge with finality how this year’s trade deadline maneuvers will play out. That said, we’re already half of the way through the period — the regular season portion, at least — for which rental players were acquired. Even players with future control are usually added first and foremost for their immediate contributions (though there are some exceptions). It’d be awfully premature to say anything conclusive about the prospect side of any deals, but we do now have some additional information with which to work.
So, that’s why we’re going to take a glance back over our shoulders at the moves (and major non-moves) that organizations made in the run-up to this year’s trade deadline. We already covered the AL Central, NL Central, and AL East; now we’ll go to the National League East …
Braves
There was an argument for the Braves to consider rotation and even outfield improvements at the trade deadline, but the club ultimately focused on the bullpen after the mid-June signing of Dallas Keuchel. Otherwise, the club swung just one other deal, a minor swap of cash for catching depth in the form of John Ryan Murphy.
So, what about those relievers? The club picked up Chris Martin (link), Shane Greene (link), and Mark Melancon (link). That seemed like a sturdy trio, but each got off to an exceptionally rocky start. Thankfully, things have stabilized. Martin sports a 15:1 K/BB rate in Atlanta; Melancon sits at 20:2 and hasn’t yet blown a save in nine chances (though it may not seem that way). Greene gave up a pair of runs in his last outing, but that broke a 13-appearance scoreless streak.
On the other side of the coin, the price paid never figured to hurt the Braves too badly, as they largely parted with upper-level pieces that were stacked behind other prospects. If there’s one that could hurt, it may be Joey Wentz, who posted a 37:4 K/BB ratio while allowing just six earned runs in 25 2/3 innings with the Tigers’ Double-A affiliate after coming over in the Greene trade. Utilityman Travis Demeritte, who went with him, has struggled in brief MLB action. The Martin swap cost another young left, Kolby Allard, who has put a shine on a solid overall campaign by running a 3.78 ERA over six big league starts. He’s succeeding largely by limiting the long ball, which may not be fully sustainable, but his stuff has trended up noticeably since his brief debut last year with Atlanta. Tristan Beck, the key piece in the Melancon swap, has generated good results at the High-A level since the deal.
So, what about the possible needs in other areas? The starting staff has continued to be an internal operation (including Keuchel). While it’s not exactly an ace-laden outfit, the Braves do have plenty of depth and will likely plan to stack pitching in the postseason rather than hoping for lengthy starts. Position-player depth has been an issue, but the club has managed to find solutions by being one of the most aggressive accumulators of players in September. Minor-league signings and claims brought the team Adeiny Hechavarria, Billy Hamilton, and Francisco Cervelli. While it’s certainly arguable the Braves could or should have made at least one more significant addition, the overall approach of supplementing the existing roster has certainly not prevented the team from performing at an impressive level of late.
Nationals
The D.C. organization pursued something like a Braves-lite strategy, landing its own trio of relief arms but doing so at another tier lower than did the division leaders. Southpaw Roenis Elias (link) and righties Daniel Hudson (link) and Hunter Strickland (link) all arrived on deadline day to buttress a bullpen that has been a source of turnover and turmoil all season long.
Elias was arguably the biggest piece of the three, but has contributed the least due to injury. It’s an unlucky break, though the Nats still can salvage value from the deal by tendering him a contract for the next two seasons to come. The two right-handers have become important pieces in the late-inning mix of the rightly maligned Washington relief corps. Hudson owns a 2.40 ERA in 15 frames, with 9.0 K/9 and 1.8 BB/9; Strickland is sitting at a 4.40 ERA over 14 1/3 innings, with 6.3 K/9 and 3.1 BB/9. They’ve each allowed three home runs.
Securing the services of Elias meant sending Elvis Alvarado and Taylor Guilbeau to Seattle. The control problems of the former disappeared in a dozen-inning rookie ball stint after the trade, so perhaps the Seattle staff helped him figure something out. Gilbeau, 26, has earned his first time in the majors. In eight innings, the southpaw has been tough on lefties (.176/.263/.294) while being knocked around a bit by righties (.267/.353/.467). Another young lefty went to Seattle in the Strickland deal. Aaron Fletcher has thrown 13 innings of 3.46 ERA ball with 15 strikeouts and three walks in 13 Double-A innings. Adding Hudson cost 23-year-old Kyle Johnston, whose solid High-A numbers have tanked since the swap. He carries a brutal 13:20 K/BB ratio in 19 2/3 innings with the new organization.
Add it all up, and the Nats can’t be terribly displeased … but also haven’t been overwhelmingly boosted by their mid-season additions. Indications are that the club was working under tight payroll constraints this summer, so that’s to be expected. Fortunately, infielder Asdrubal Cabrera came cheap. He has been aflame since being signed as a September free agent. The club is still in very good position for the Wild Card, but has to wonder how far it will be able to advance with such an unreliable relief unit.
Phillies
After adding Jay Bruce earlier in the summer, the Phillies probably wanted to improve their pitching. But they didn’t end up matching their rivals in that regard — not even close, in fact.
Outfielder Corey Dickerson was the team’s biggest addition in the run-up to the deadline, in fact. The primary cost was his remaining salary, with the club also agreeing to send the cross-state Pirates some international bonus capacity and a PTBNL. Dickerson may not even have been added had it not been for Bruce’s health issues. It has turned out to be wise move, as Dickerson carries a .300/.313/.592 batting line through 134 plate appearances.
Taking on money was also a driver in the Jason Vargas deal. The veteran southpaw has taken the ball eight times for the Phillies, managing a 5.01 ERA over 41 1/3 innings with a 1.63 K/BB ratio. That’s a downgrade from the results he posted with the Mets before the trade — 4.01 ERA with 2.08 K/BB ratio — though he’s much the same pitcher by most measures.
Those moves have certainly helped the Phils hang in the Wild Card race, though the club could obviously have stood to make greater improvements. Minor deals for Mike Morin, Jose Pirela, and Dan Straily haven’t delivered a ton of benefit. Morin has seen 21 innings of action but owns a 5.14 ERA. Pirela has seen limited action in the majors, while Straily hasn’t been asked onto the 40-man roster.
Much like their competitors in the division, the Phils have made several additions by signing released players or placing post-deadline claims. Those methods have brought in Drew Smyly, Blake Parker, Nick Vincent, Logan Morrison, and Jared Hughes to help keep things afloat. While more significant reinforcements surely would’ve been preferred, the organization just wasn’t willing to pay what it would have cost.
Mets
The most surprising deadline approach came from New York, with the Mets deciding to chase dwindling postseason aspirations. While the organization was rewarded with an inspired run of play, it still seems likely the club will fall short of its goal.
It seemed as the deadline drew nigh that the Mets would function as sellers. Zack Wheeler was an obvious trade piece, with a variety of other veterans also possibilities to move. Instead, the club pursued a stunning swap for local product Marcus Stroman while sending Vargas to the Phils to help offset the cash.
Parting with Vargas hasn’t hurt, though it was curious to see him go to a division rival. Trouble is, Stroman hasn’t been any better. He’s carrying a 5.05 ERA in 35 2/3 frames. While he’s surely a better bet going forward than the aging lefty, Stroman will need to rein in the number of balls leaving the yard (1.8 per nine since the deal). Adding Stroman meant that the Mets ponied up another chunk of young talent from a farm that had already parted with key pieces. Most analysts felt the cost — Anthony Kay and Simeon Woods Richardson — was rather reasonable, though both hurlers have trended up since joining their new organization.
The real head-scratcher in all of this was that the Mets stopped with only the addition of Stroman. He was and is a piece with 2020 value as well, of course, but the club left its bullpen entirely unimproved. The club did go on to add Brad Brach as well as second bagger Joe Panik when they came available in September. Brodie Van Wagenen’s first trade deadline will be an interesting one to revisit down the line.
Marlins
It was a low-key fascinating trade period for the Fish. Not because they made sell-side moves — that was obvious — but because they ended up shipping out young talent.
It all got started innocently enough, as rental reliever Sergio Romo was sent to the Twins in a deal that netted first baseman Lewin Diaz. The youngster’s batting average and OBP dove with his new club, but he is still showing good power at Double-A. Unfortunately, the deal also cost the Fish 22-year-old righty Chris Vallimont. He had put up solid numbers all season long and finished with a bang, posting a 28:4 K/BB ratio and 3.63 ERA over 22 1/3 High-A innings.
It might have been supposed that the Marlins would try to spin off a few other veterans, with Neil Walker and Curtis Granderson among the short-term players that could hypothetically have been moved. Instead, the Miami club turned to cashing in controllable MLB pitching for buy-low position-player prospects.
First came an intriguing intra-state deal. The Marlins parted with righties Nick Anderson and Trevor Richards in order to pick up young outfielder Jesus Sanchez and reliever Ryne Stanek. With Anderson dominating and Richards performing quite well, there could be some second-guessing here. Then again, Sanchez is a well-regarded young player. He slashed .246/.338/.446 in 78 plate appearances at Triple-A after the swap. That’s hardly a big showing in this year’s hot offensive environment, but it was an improvement over his work in the Rays organization and he’s still just 21 years of age.
At least as surprising was the deal that saw rookie righty Zac Gallen head to the D-Backs in exchange for Jazz Chisholm. Entering the season, this swap would’ve seemed ridiculous. But the two players involved headed in quite different directions. By the time the deal was struck, the former was in the midst of a breakout season, with the age and cheap control needed to serve as a part of a new core. But the Marlins elected to cash in his breakout to take a shot at the long-lauded Chisholm, who had shown big strikeout numbers at Double-A (33.8%). Gallen has continued to excel in Arizona, raising the stakes for Chisholm. But the 21-year-old shortstop did trend up after the move, paring back the Ks and slashing .284/.383/.494 (156 wRC+) in 94 plate appearances with the Marlins’ Double-A affiliate.
It’s impossible to say how this slate of transactions will look in the long run, but it’ll be fun to track these intriguing deals from the rebuilding Marlins.
Pat Neshek Undergoes Hamstring Surgery
Veteran righty Pat Neshek has undergone surgery to repair his injured right hamstring, Scott Lauber of the Philadelphia Inquirer reports on Twitter. Neshek had been weighing a procedure against other potential courses of action.
Obviously, this news means that the hurler isn’t going to return to the field of play in 2019. It’s all but certain he won’t be back with the Phillies next year, at least not under his existing contract. The club will surely pay him a $750K buyout rather than picking up an option at $7MM.
Whether Neshek will attempt to work back and continue pitching remains to be seen. He doesn’t have anything to prove after 13 productive years in the majors, even if this last campaign did not go according to plan. But the crafty hurler would be sure to find an opportunity to compete for a job in camp if he’s interested.
This was Neshek’s worst campaign in quite some time. He ended up with a 5.00 ERA over 18 innings with just nine strikeouts and five home runs allowed. But he had been on an extended run of productivity before that, including an injury-shortened ’18 effort in Philadelphia in which he pitched to a 2.59 ERA over 24 1/3 innings.
In other Philly bullpen news, the club is seeing progress from righties Juan Nicasio and Seranthony Dominguez, though it still seems that any contributions will come quite late (if at all). The former got back on the bump today while the latter is ten days out from his first work from the hill. Though Nicasio is slated to reach free agency at season’s end, Dominguez could be an important part of the 2020 Phillies relief corps if he can continue to make progress with his elbow health.
X-Rays Negative On Bryce Harper's Hand
After being hit in the right hand with a Steven Matz pitch on Friday, Bryce Harper sat out the Phillies’ 5-0 win over the Mets today and could also miss Sunday’s game. X-rays were negative on the injury and Harper told the Philadelphia Inquirer’s Matt Breen and other reporters that he would “be fine,” though he was frustrating at having to miss any time at all during the pennant race. “Really tough to take a day [off], but I need to do what I need to do,” Harper off. The Phils’ victory moved them three games behind the Cubs for the last NL wild card berth, and in the midst of such a tight race, certainly can’t afford to miss one of their top players.
After being hit in the right hand with a Steven Matz pitch on Friday, Bryce Harper sat out the Phillies’ 5-0 win over the Mets today and could also miss Sunday’s game. X-rays were negative on the injury and Harper told the Philadelphia Inquirer’s Matt Breen and other reporters that he would “be fine,” though he was frustrating at having to miss any time at all during the pennant race. “Really tough to take a day [off], but I need to do what I need to do,” Harper off. The Phils’ victory moved them three games behind the Cubs for the last NL wild card berth, and in the midst of such a tight race, certainly can’t afford to miss one of their top players.
While Harper hasn’t quite posted the type of superstar-level numbers you might expect after signing his much-ballyhooed 13-year, $330MM contract last offseason, he has been a thoroughly productive player in his first Phillies season, hitting .254/.372/.497 with 30 homers over an even 600 plate appearances while also contributing strong defense.
Seranthony Dominguez Making Progress
- The Phillies got some promising news on righty reliever Seranthony Dominguez, who has at times seemed destined to miss the rest of the season. Despite a recent scare, he has shown enough progress in his elbow health to resume throwing, manager Gabe Kapler told reporters including Jim Salisbury of NBC Sports Philly (via tweet). It’s still not clear that Dominguez will have enough time to ramp up and return to active duty, though perhaps there’s still an outside shot.
Phillies Release Drew Anderson
The Phillies announced today that they have released right-hander Drew Anderson after he cleared waivers. He had been designated for assignment recently.
Anderson, a 25th-round pick in 2012, has had success at times as a starter in the upper minors. But he has struggled in limited MLB action, coughing up 18 earned runs on 29 hits in 21 total frames.
It has been a rough overall campaign for Anderson, who has been sidelined since late June and was ineffective before that. Over 11 starts at the Triple-A level, he managed only a 5.77 ERA with 7.4 K/9 against 5.0 BB/9.
Latest On Jeremy Jeffress
Right-hander Jeremy Jeffress, officially released by the Brewers yesterday, has drawn some level of interest from several teams, tweets Yahoo’s Matt Ehalt. The Reds, Mets, Phillies, Rays and even the Brewers are among the teams who’ve inquired about the 2018 All-Star.
Jeffress isn’t postseason eligible, having been cut loose in September, but some of the interested teams would apparently like to proactively lock him up to a deal that covers the 2020 campaign (perhaps via a club option). That’d help to explain Milwaukee’s reported interest in bringing the righty back; the Brewers clearly had no intention of exercising Jeffress preexisting $4.3MM option for the 2020 season, but they (or another suitor) could conceivably try to hammer out an option at a lower base salary with some additional incentives. Any team signing Jeffress would only owe him the prorated league minimum for the remainder of the current season.
It’s also possible, though, that Jeffress could simply sit out the remainder of the season and explore opportunities this winter. He was on the injured list due to a hip ailment at the time of his release, and there’d surely be some benefit to an extended period of rest for the righty. He’ll likely have offseason minor league offers with decent base salaries (though less than the previous $4.3MM) at the very least, meaning there’s no rush to sign at the moment. There’ll surely be teams who are only interested in adding him after the current season draws to a close, so waiting until November to take a deal would widen his market.
Open-market circumstances surrounding Jeffress will always be somewhat atypical, given the right-hander’s history. He’s served multiple minor league suspensions for drugs of abuse (i.e. marijuana) and was charged with a DWI while pitching for the Rangers in 2016. That track record surely contributed to the club-friendly deal Jeffress signed with Milwaukee prior to the 2018 season, which came with two team options at relatively low base rates and plenty of yearly incentives based on innings pitched and games finished.
Jeffress’ release earlier this week marked the end of a radical downturn in performance. The right-hander logged a 1.29 ERA with 10.5 K/9, 3.2 BB/9, 0.59 HR/9 and a 56.4 percent ground-ball rate in last year’s All-Star season before unraveling in the playoffs. He then missed the first several weeks of the 2019 season due to shoulder fatigue.
Upon activation in mid-April, Jeffress pitched well for two months, logging a 2.52 ERA and a 26-to-9 K/BB ratio through his first 22 appearances (25 innings). Since that time, he’s scuffled with an ERA north of 7.00 and a deflated strikeout rate. Jeffress’ velocity has actually improved a bit as he’s distanced himself from the early shoulder fatigue, but the aforementioned hip ailment has added another injury to the ledger. In all, he’s turned in 52 innings with a 5.02 ERA, 8.0 K/9, 2.7 BB/9, 1.00 HR/9 and a 48.4 percent ground-ball rate while enduring a pair of IL stints in 2019. The upside a healthy Jeffress brings to the table is enormous, but he’s struggled to produce consistent results over the past three seasons.
Latest On Seranthony Dominguez
Phillies right-hander Seranthony Dominguez has spent much of the 2019 season trying to avoid Tommy John surgery, though an upcoming medical examination could finally send the former closer under the knife. As manager Gabe Kapler told NBC Sports Philadelphia’s Jim Salisbury and other reporters, Dominguez will be examined by the head of the Phillies medical staff this week after the righty experienced elbow soreness during his most recent throwing session.
Dominguez has been sidelined since early June, and it seemed like surgery was all but assured after tests revealed a damaged ulnar collateral ligament. Instead, Dominguez opted for a PRP treatment after a consultation with Dr. James Andrews, in the hopes that the reliever could potentially heal in time for a return before season’s end. Now, “one would suspect that surgery is a strong possibility” if Dominguez is still sore after all this time, Salisbury writes.
After bursting into the majors with an impressive 2018 rookie season, Dominguez’s performance took a step back, though he was still largely an effective reliever over 24 2/3 frames for the 2019 Phillies. Dominguez posted a 4.01 ERA, 10.6 K/9, 54.5% grounder rate, and 2.42 K/BB, though an increased homer rate and big BABIP jump (.220 in 2018 to .323 in 2019) conspired to boost the 24-year-old’s ERA over a full run beyond his 2.95 mark from last season.
Though Dominguez wasn’t expected to factor into save situations quite as often, the Phillies were still excited to see what the homegrown product with the 97.8 mph fastball could do in his sophomore campaign. Instead, Dominguez was one of a seemingly endless string of injured Philadelphia relievers, and should Tommy John surgery indeed be his fate, he’ll also miss the entire 2020 season.
Phillies Announce Roster Moves
5:26PM: In other roster moves, the Phillies activated Jay Bruce from the 10-day injured list and called up left-hander Cole Irvin from Triple-A. The club also selected the contracts of infielder Phil Gosselin, righty Nick Vincent, and catcher Deivy Grullon from Triple-A. This will mark the 23-year-old Grullon’s first taste of MLB action, after a seven-year stint in Philadelphia’s minor league system that includes an impressive .283/.354/.496 slash line over 457 Triple-A plate appearances this season.
3:38PM: The Phillies have designated right-handed pitcher Drew Anderson for assignment, according to an official team announcement. He’ll be dropped from the team’s 40-man roster, along with Adam Morgan and Jerad Eickhoff, who were transferred to the 60-day injured list.
The 25-year-old Anderson has only managed to get into two games for the Phillies this year, tossing six innings in his third big-league season. It hasn’t been a promising showing for Anderson, who surrendered five runs in those six innings, walking as many batters as he struck out. Unfortunately, those numbers represented a continuation of his struggles in his first two trials in Philadelphia. For his career, Anderson is sporting an unsightly 7.71 ERA over 21 innings of work.
What’s more, the minor-league numbers for Anderson haven’t been much more encouraging. While he’s excelled at Double-A, it seems that Triple-A has represented a significant barrier; across three seasons at the level, Anderson owns a 4.34 ERA while striking out only 7.4 batters per nine innings. If he clears waivers, he could accept an outright assignment and remain within the Philly organization — if he isn’t released. Otherwise, another team could take a chance on him and hope to turn him into a viable reliever.
Phillies Shut Down Three Pitchers
- The Phillies were just 3.0 games back in the NL Wild Card race entering play Saturday, but the team can count out three of their pitchers for the rest of the year. According to a tweet from Todd Zolecki of MLB.com (link), Philadelphia hurlers Seranthony Dominguez (elbow soreness), Adam Morgan (elbow), and Pat Neshek (hamstring) will all be held out through season’s end. None of these pitchers have appeared in August action; all were expected to be key contributors to the Philadelphia staff this year, which helps explain how the Phillies pen has struggled to a collective 4.70 ERA on the year (20th in MLB).
